Navigation Links
With Peripheral Artery Disease, Med Adherence Is Low
Date:4/24/2009

Survival, though, is greater when guidelines are followed, study finds

FRIDAY, April 24 (HealthDay News) -- Less than half of those who have peripheral artery disease are taking the recommended combination of medications to control it, new research says.

Researchers collected data on 711 people with peripheral artery disease who had vascular surgery at 11 hospitals in the Netherlands in 2004. Three years later, 465 of the surviving 552 patients answered a questionnaire about their medication use.

About half were taking the guideline-recommended medical therapy, a combination of aspirin and statins in all patients and beta blockers in those who also had ischemic heart disease, said study author Dr. Don Poldermans, of the Erasmus Medical Center in Rotterdam.

Those who were taking the recommended medications had a better chance of being alive three years after their surgery, the study found.

Researchers also found that after three years, aspirin was being taken by 74 percent, statins by 69 percent and beta blockers by 54 percent.

"Guideline-recommended medical therapy use for the combination of aspirin, statins and beta blockers ... was lower than expected," the authors said in a news release from the American Heart Association. "These data clearly indicate the need for initiating optimal medical treatment at the preoperative outpatient clinic, as well as improvement of long-term medication use."

Their research was to be presented Friday at the American Heart Association's 10th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke in Washington, D.C. and will be published in Circulation: Cardiovascular Outcomes and Quality.

Peripheral artery disease is a circulatory problem in which narrowed arteries reduce blood flow to the limbs. Symptoms typically include leg pain when walking.

The disease is also often a sign of atherosclerosis, a chronic inflammation and build-up of plaques in the arteries, which can reduce blood flow to the heart, brain and legs.

More information

The American Heart Association has more on peripheral artery disease.



-- Jennifer Thomas



SOURCE: American Heart Association, news release, April 24, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
2. Riverside First to Offer New Treatment for Peripheral Arterial Disease
3. New Device for Clearing Blocked Arteries in the Legs Receives FDA Clearance for Peripheral Use - Procedures Performed Across the US Within First 48 Hours
4. Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products
5. Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System
6. American College of Physicians publishes "Peripheral Arterial Disease"
7. Peripheral Artery Disease Up Sharply Among U.S. Women
8. Asymptomatic peripheral artery disease prevalence is rising
9. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
10. Peripheral Arterial Disease Costlier to Treat Than Heart Trouble
11. Terumo Launches the New AZUR(TM) Peripheral HydroCoil(R) Embolization System with Expanding Hydrogel Technology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
With Peripheral Artery Disease, Med Adherence Is Low
(Date:9/20/2017)... , ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of ... is the creation of published author, Jeanine Liston, a busy mother of five who used ... “I have been writing this book for over twenty years. It was a way ...
(Date:9/19/2017)... Houston, Texas (PRWEB) , ... September 19, 2017 ... ... Win Promotions and the Brazilian jiu-jitsu community have raised more than $15,000 in ... to the mats in professional submission grappling matches and world-class instructor seminars, organizers ...
(Date:9/19/2017)... , ... September 19, 2017 , ... Trusted debt-reduction firm ... 175,000 debt accounts, translating to in excess of $835 million in resolved debt for ... other unsecured loans are some of the categories of debt settled by the company. ...
(Date:9/19/2017)... Hill, CT (PRWEB) , ... September 19, 2017 ... ... support, today announced the winners of the Entrepreneur Innovation Awards (EIA), held this ... all of whom are Connecticut-based companies and entrepreneurs, presented their innovative project ideas ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... Society of Professional Benefit Administrators (SPBA) hosted “Expanding Your Success” with an ... Members as it focused on best practices for third party administrators (TPAs) related ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent ... as the number one company for hearing aids, ranking it ... fifteen other brands. ... Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
(Date:9/7/2017)... -- NuvoAir (formerly called Pond Healthcare Innovation), the ... with Novartis Pharma AG to distribute NuvoAir,s spirometry technology to ... mobile spirometry platform and Novartis, commitment to address the unmet ... ... ...
Breaking Medicine Technology: